Exclusive special offer and discount title banner vector image

GLOBAL SINGLE-USE BIOPROCESSING MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

Global Single-Use Bioprocessing Market by Product (Disposable Mixers, Single-use Bioreactors, Single-use Assemblers, Tubing Assemblies, Depth Filters, Tangential-flow Filtration Devices) Market by Application (Monoclonal Antibody Production, Plant Cell Cultivation, Patient-specific Cell Therapies, Vaccine Production) Market by Method (Filtration, Storage, Mixing, Purification, Cell Culture) Market by End-user (Biopharmaceutical Manufacturers, Contract Research Organization and Manufacturers, Life Science R&d Companies and Academic Research) by Geography


MARKET OVERVIEW

The global single-use bioprocessing market is expected to grow at a CAGR of 15.66% during the forecast period 2024-2032

Single-use bioprocessing utilizes disposable plastic equipment like bioreactor bags, tubes, and connectors in place of conventional fixed stainless steel vessels. It enables more customizable and modular facility designs catered to the unique needs of different biologics production processes. Companies are increasing adoption to benefit from reduced cross-contamination risks between product batches, decreased facility downtime from stringent cleaning requirements of steel equipment, and enhanced flexibility in production scale-up/scale-down. Moreover, the utilization of single-use components simplifies validation documentation by reducing complexity. 

As the biopharmaceutical industry experiences rapid expansion, so does the demand for innovative biomanufacturing solutions that can accelerate production and scale efficiently. Opting for disposable plastic components rather than permanent stainless steel equipment can offer increased flexibility, reduced downtime, and simplified validation requirements. This approach directly addresses the growing demands of both clinical-stage and commercial biologics manufacturers, providing a configurable and cost-effective capacity solution.

Single-Use Bioprocessing Market

Read our latest blog on the Single-Use Bioprocessing Market

GROWTH ENABLERS

Key growth enablers of the global single-use bioprocessing market: 

  • Growing biopharma industry and rising biologics demand
    • The rapid growth of the biopharmaceutical industry and increasing demand for biologic drugs are key factors driving the adoption of single-use bioprocessing technologies. As more biologics progress through development pipelines and reach commercial manufacturing, there is a heightened need for flexible, scalable production solutions that can improve efficiency. Single-use bioreactors, mixers, tubing, and other plastic disposable components enable greater manufacturing agility, shorter changeover times between batches, and reduced contamination risks. 
    • Additionally, the customizable and modular nature of single-use systems allows biomanufacturers to rapidly pivot operations and adapt to fluctuating product demand. As the industry continues expanding its output of complex biologics-based therapeutics, these production advantages of single-use bioprocessing perfectly align with manufacturers’ priorities around cost and speed-to-market. 
  • Flexibility and cost-efficiency over stainless steel equipment
  • Increased R&D spending and innovations in SU technologies
  • Focus on efficiency and quality in bioprocessing
  • Adoption of continuous manufacturing and process intensification

GROWTH RESTRAINTS

Key growth restraining factors of the global single-use bioprocessing market: 

  • Issues with extractable and leachable in single-use systems
  • Limitations in scaling up (>2,000l) using single-use bioreactors
  • Lack of long-term stability data for some polymers
    • Plastic equipment offers benefits in pharmaceutical manufacturing. The limited availability of long-term stability data for certain polymer components acts as a constraint to their widespread adoption in pain medication and device production processes. Additionally, the intricate manufacturing requirements of analgesic biologics and implantable neuromodulation devices contribute to delays in achieving the necessary safety and efficacy profiles for clinical use.
    • Regulators require extensive stability testing data to ensure there are no risks of container components leaching or impairing final production quality over time. Accumulating stability datasets spanning 10 to 20 years for all plastics has proven to be a challenging task. Therefore, manufacturers striving to balance innovation objectives with patient safety requirements face difficulties in fully validating plastic systems for long-term commercial scalability across various pain applications, thereby impeding widespread adoption.
  • Requirement for additional storage and disposal logistics
  • Perceived risk of contamination in single-use equipment

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Single-Use Bioprocessing Market | Top Market Trends 

  • Automation technology is being increasingly integrated with single-use bioprocessing equipment to reduce manual operation and contamination risks. This allows users to program and control various processes like media transfer and sampling digitally. Automated single-use systems provide consistent results and process optimization. Additionally, they minimize personnel requirements and human errors while meeting regulatory compliance guidelines. Overall, automation enhances reliability, efficiency, quality, and flexibility for end users. The technology presents an impactful trend in the single-use bioprocessing space.
  • Innovative single-use sensor technologies for real-time monitoring and control are gaining strong interest. These sensors enable precise in-line tracking of parameters like pH, temperature, cell density, and dissolved gases. The sensor data allows for automated process optimization to enhance yields/quality. Moreover, it provides a complete process record for troubleshooting and compliance purposes. The non-invasive disposable sensors minimize contamination risks associated with traditional probes. Overall, these advancements significantly improve process management while retaining the simplicity of single-use systems.

MARKET SEGMENTATION

Market Segmentation – Product, Application, Method, and End-User –

Market by Product:

  • Disposable Mixers
    • Disposable mixers are an integral product category within single-use bioprocessing systems, fulfilling specialized blending and liquid handling needs in biopharma manufacturing. Unlike traditional fixed tank agitators, single-use mixers feature sealed housings and impellers processing fluid volumes from 50 milliliters to 1,000 liters suitable for cell culture and buffer preparation applications. 
    • Significant advantages revolve around contamination control achieved through fully enclosed operations, eliminating the need for CIP/SIP cleaning between batches. Additional benefits encompass streamlined validation processes, quicker changeovers facilitated by disposability, and precise control over processes for shear-sensitive cultures made possible through the integration of sensors.
    • With the growing use of mammalian and microbial cell hosts in biologics, the importance of scalable single-use mixers becomes increasingly clear. This is important for maintaining optimal environmental conditions, enhancing product yield, and preventing aggregation issues spanning from process development to commercialization.
  • Single-Use Bioreactors
  • Single-Use Assemblers
  • Tubing Assemblies
  • Depth Filters
  • Tangential-Flow Filtration Devices

Market by Application:

  • Monoclonal Antibody Production
    • Monoclonal antibody production refers to manufacturing processes that produce homogeneous antibodies that bind to a single epitope. This involves using cell culture techniques to derive antibody-generating immune cells like plasma B cells that are then immortalized as monoclonal cell lines capable of secreting large quantities of identical antibodies indefinitely. 
    • Biomanufacturers are increasingly integrating single-use bioprocessing technologies when developing and scaling up monoclonal antibody manufacturing. Benefits include lower contamination risks, operational flexibility, and modular scalability that disposable equipment provides relative to traditional, fixed stainless steel systems. 
    • The increasing use of single-use bioreactors, mixers, and purification systems in the development and commercialization of modern antibody therapies fosters strong synergies, contributing to ongoing expansion.
  • Plant Cell Cultivation
  • Patient-Specific Cell Therapies
  • Vaccine Production

Market by Method:

Market by End-User:

  • Biopharmaceutical Manufacturers
  • Contract Research Organization and Manufacturers
  • Life Science R&D Companies and Academic Research

GEOGRAPHICAL STUDY

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
    • Contract manufacturing organizations (CMOs) are playing an increasingly important role in the Asia-Pacific single-use bioprocessing market. The complexities of biologics manufacturing are driving more biopharma companies to partner with CMOs that have expertise in single-use technologies and can enhance flexibility and speed. 
    • Rapid economic growth has boosted healthcare spending in countries like China, India, and Indonesia. The combination of higher incomes and government initiatives to modernize infrastructure is substantially increasing resources available for the domestic biopharmaceutical market.
    • Major CMOs expanding single-use manufacturing capacities in Asia-Pacific include WuXi Biologics, Boehringer Ingelheim, Lonza, and Samsung Biologics. 
    • They are initiating new facilities and offering comprehensive solutions by utilizing single-use bioreactors up to 2000L. Furthermore, factors such as reduced operating costs, enhanced productivity, and quicker time to market are fostering the adoption of these practices among CMOs in the APAC region.
  • Rest of World: Latin America, the Middle East & Africa

MAJOR PLAYERS

Major players in the global single-use bioprocessing market: 

  • Sartorius AG 
  • Danaher Corp 
  • Thermo Fisher Scientific Inc 
  • Merck KGaA 
  • Avantor Inc

Key strategies adopted by some of these companies: 

  • In March 2023, Thermo Fisher announced an expanded collaboration with Arsenal Bio to optimize manufacturing processes for next-generation programmed T-cell therapies for cancer.
  • Thermo Fisher, in January 2023, launched its Orbitrap Astral mass spectrometer, enabling researchers to detect previously undetectable proteins for biopharma and clinical applications.
  • In November 2022, Avantor opened a 69,000 sq ft distribution center near Dublin featuring cGMP warehousing, quality control and logistics solutions for biopharma customers.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments AnalyzedProduct, Application, Method, and End-User
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies AnalyzedSartorius AG, Danaher Corp, Thermo Fisher Scientific Inc, Merck KGaA, Avantor Inc, Eppendorf SE, Corning Inc, Boehringer Ingelheim International GmbH, Lonza, Infors AG, PBS Biotech Inc, Entegris Inc, Kuhner AG, Meissner Filtration Products Inc, Rentschler Biopharma SE

TABLE OF CONTENTS

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. MAJOR MARKET FINDINGS
      1. RISING CONTINUOUS MANUFACTURING, MODULAR FACILITY DESIGNS, END-TO-END INTEGRATED SOLUTIONS USE SINGLE-USE TECHNOLOGY
      2. GROWING DEMAND FOR SINGLE-USE MIXING SYSTEMS, CONNECTORS, BIOBAGS
      3. HYBRID APPROACH COMBINING STAINLESS STEEL AND SINGLE-USE SYSTEMS GAINING TRACTION
      4. ADVANCES IN POLYMER SCIENCE LEADING TO INNOVATIVE FILMS, CONNECTORS, SENSORS FOR IMPROVED PERFORMANCE
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. GROWING BIOPHARMA INDUSTRY AND RISING BIOLOGICS DEMAND
      2. FLEXIBILITY AND COST-EFFICIENCY OVER STAINLESS STEEL EQUIPMENT
      3. INCREASED R&D SPENDING AND INNOVATIONS IN SU TECHNOLOGIES
      4. FOCUS ON EFFICIENCY AND QUALITY IN BIOPROCESSING
      5. ADOPTION OF CONTINUOUS MANUFACTURING AND PROCESS INTENSIFICATION
    2. KEY RESTRAINTS
      1. ISSUES WITH EXTRACTABLE AND LEACHABLE IN SINGLE-USE SYSTEMS
      2. LIMITATIONS IN SCALING UP (>2,000L) USING SU BIOREACTORS
      3. LACK OF LONG-TERM STABILITY DATA FOR SOME POLYMERS
      4. REQUIREMENT FOR ADDITIONAL STORAGE AND DISPOSAL LOGISTICS
      5. PERCEIVED RISK OF CONTAMINATION IN SINGLE-USE EQUIPMENT
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. AUTOMATION OF SINGLE-USE SYSTEMS
      2. ADVANCED SINGLE-USE SENSORS FOR PROCESS MONITORING/CONTROL
      3. INNOVATIVE SINGLE-USE BIOREACTOR DESIGNS FOR SCALABLE MANUFACTURING
      4. OPTIMIZED SINGLE-USE DOWNSTREAM PROCESS EQUIPMENT 
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED STATES
      2. GROWTH PROSPECT MAPPING FOR GERMANY 
      3. GROWTH PROSPECT MAPPING FOR CHINA 
      4. GROWTH PROSPECT MAPPING FOR SAUDI ARABIA 
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
    6. VALUE CHAIN ANALYSIS
      1. RAW MATERIAL SUPPLIERS
      2. SINGLE-USE BIOPROCESSING EQUIPMENT MANUFACTURERS
      3. LOGISTICS AND DISTRIBUTION PARTNERS 
      4.  BIOPHARMACEUTICAL COMPANIES AND RESEARCH INSTITUTIONS
    7. KEY BUYING CRITERIA
      1. PROCESS COMPATIBILITY AND BIOCOMPATIBILITY
      2. INNOVATIVE SINGLE-USE TECHNOLOGIES
      3. INTEGRITY AND STERILITY ASSURANCE
      4. TECHNICAL AND REGULATORY COMPLIANCE SUPPORT
  5. MARKET BY PRODUCT
    1. DISPOSABLE MIXERS
    2. SINGLE-USE BIOREACTORS
    3. SINGLE-USE ASSEMBLERS
    4. TUBING ASSEMBLIES
    5. DEPTH FILTERS
    6. TANGENTIAL-FLOW FILTRATION DEVICES 
  6. MARKET BY APPLICATION 
    1. MONOCLONAL ANTIBODY PRODUCTION
    2. PLANT CELL CULTIVATION
    3. PATIENT-SPECIFIC CELL THERAPIES
    4. VACCINE PRODUCTION 
  7. MARKET BY METHOD 
    1. FILTRATION
    2. STORAGE
    3. MIXING
    4. PURIFICATION
    5. CELL CULTURE
  8. MARKET BY END-USER
    1. BIOPHARMACEUTICAL MANUFACTURERS
    2. CONTRACT RESEARCH ORGANIZATION AND MANUFACTURERS
    3. LIFE SCIENCE R&D COMPANIES AND ACADEMIC RESEARCH
  9. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET DRIVERS
      3. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET CHALLENGES
      4. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE SINGLE-USE BIOPROCESSING MARKET DRIVERS
      3. EUROPE SINGLE-USE BIOPROCESSING MARKET CHALLENGES
      4. EUROPE SINGLE-USE BIOPROCESSING MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN EUROPE SINGLE-USE BIOPROCESSING MARKET
      6. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        6. BELGIUM
          1. BELGIUM SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        7. POLAND
          1. POLAND SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        8. REST OF EUROPE
          1. REST OF EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET DRIVERS
      3. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET CHALLENGES
      4. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET
      6. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        5. THAILAND
          1. THAILAND SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        6. VIETNAM
          1. VIETNAM SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        7. INDONESIA
          1. INDONESIA SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        8. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        9. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD SINGLE-USE BIOPROCESSING MARKET DRIVERS 
      3. REST OF WORLD SINGLE-USE BIOPROCESSING MARKET CHALLENGES
      4. REST OF WORLD SINGLE-USE BIOPROCESSING REGULATORY FRAMEWORK
      5. KEY PLAYERS IN REST OF WORLD SINGLE-USE BIOPROCESSING MARKET
      6. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST & AFRICA
          1. MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE & OPPORTUNITIES
  10. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. SARTORIUS AG
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      2. DANAHER CORP
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      3.  THERMO FISHER SCIENTIFIC INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      4. MERCK KGAA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5.  AVANTOR INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      6.  EPPENDORF SE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      7.  CORNING INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      8.  BOEHRINGER INGELHEIM INTERNATIONAL GMBH
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
        3. STRENGTHS & CHALLENGES
      9. LONZA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      10.  INFORS AG
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
        3. STRENGTHS & CHALLENGES
      11.  PBS BIOTECH INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      12. ENTEGRIS INC
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
        3. STRENGTHS & CHALLENGES
      13.  KUHNER AG
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      14.  MEISSNER FILTRATION PRODUCTS INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      15.  RENTSCHLER BIOPHARMA SE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – SINGLE-USE BIOPROCESSING MARKET 

TABLE 2: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: GLOBAL DISPOSABLE MIXERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GLOBAL DISPOSABLE MIXERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: GLOBAL SINGLE-USE BIOREACTORS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: GLOBAL SINGLE-USE BIOREACTORS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: GLOBAL SINGLE-USE ASSEMBLERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GLOBAL SINGLE-USE ASSEMBLERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: GLOBAL TUBING ASSEMBLIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: GLOBAL TUBING ASSEMBLIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 12: GLOBAL DEPTH FILTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: GLOBAL DEPTH FILTERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 14: GLOBAL TANGENTIAL-FLOW FILTRATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: GLOBAL TANGENTIAL-FLOW FILTRATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 16: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 18: GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: GLOBAL MONOCLONAL ANTIBODY PRODUCTION BIOPROCESSING MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 20: GLOBAL PLANT CELL CULTIVATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 21: GLOBAL PLANT CELL CULTIVATION MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 22: GLOBAL PATIENT-SPECIFIC CELL THERAPIES MARKET, BY REGION, HISTORICAL YEARS 2018-2022 (IN $ MILLION)

TABLE 23: GLOBAL PATIENT-SPECIFIC CELL THERAPIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 24: GLOBAL VACCINE PRODUCTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 25: GLOBAL VACCINE PRODUCTION MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 26: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY METHOD, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 27: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY METHOD, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 28: GLOBAL FILTRATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 29: GLOBAL FILTRATION MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 30: GLOBAL STORAGE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 31: GLOBAL STORAGE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 32: GLOBAL MIXING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 33: GLOBAL MIXING MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 34: GLOBAL PURIFICATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 35: GLOBAL PURIFICATION MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 36: GLOBAL CELL CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 37: GLOBAL CELL CULTURE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 38: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 39: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 40: GLOBAL BIOPHARMACEUTICAL MANUFACTURERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 41: GLOBAL BIOPHARMACEUTICAL MANUFACTURERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 42: GLOBAL CONTRACT RESEARCH ORGANIZATION AND MANUFACTURERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 43: GLOBAL CONTRACT RESEARCH ORGANIZATION AND MANUFACTURERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 44: GLOBAL LIFE SCIENCE R&D COMPANIES AND ACADEMIC RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 45: GLOBAL LIFE SCIENCE R&D COMPANIES AND ACADEMIC RESEARCH MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 46: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 47: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY GEOGRAPHY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 48: NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 49: NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 50: NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET REGULATORY FRAMEWORK

TABLE 51: KEY PLAYERS OPERATING IN NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET

TABLE 52: EUROPE SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 53: EUROPE SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 54: EUROPE SINGLE-USE BIOPROCESSING MARKET REGULATORY FRAMEWORK

TABLE 55: KEY PLAYERS OPERATING IN EUROPE SINGLE-USE BIOPROCESSING MARKET

TABLE 56: ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 57: ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 58: ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET REGULATORY FRAMEWORK

TABLE 59: KEY PLAYERS OPERATING IN ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET

TABLE 60: REST OF WORLD SINGLE-USE BIOPROCESSING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 61: REST OF WORLD SINGLE-USE BIOPROCESSING MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 62: REST OF WORLD SINGLE-USE BIOPROCESSING MARKET REGULATORY FRAMEWORK

TABLE 63: KEY PLAYERS OPERATING IN REST OF WORLD SINGLE-USE BIOPROCESSING MARKET

TABLE 64: LIST OF MERGERS & ACQUISITIONS

TABLE 65: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 66: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 67: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: GROWTH PROSPECT MAPPING FOR GERMANY 

FIGURE 5: GROWTH PROSPECT MAPPING FOR CHINA 

FIGURE 6: GROWTH PROSPECT MAPPING FOR SAUDI ARABIA

FIGURE 7: MARKET MATURITY ANALYSIS

FIGURE 8: MARKET CONCENTRATION ANALYSIS

FIGURE 9: GLOBAL SINGLE-USE BIOPROCESSING MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023

FIGURE 10: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY DISPOSABLE MIXERS, 2024-2032 (IN $ MILLION)

FIGURE 11: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY SINGLE-USE BIOREACTORS, 2024-2032 (IN $ MILLION)

FIGURE 12: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY SINGLE-USE ASSEMBLERS, 2024-2032 (IN $ MILLION)

FIGURE 13: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY TUBING ASSEMBLIES, 2024-2032 (IN $ MILLION)

FIGURE 14: GLOBAL SINGLE-USE BIOPROCESSING MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 15: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY MONOCLONAL ANTIBODY PRODUCTION, 2024-2032 (IN $ MILLION)

FIGURE 16: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY PLANT CELL CULTIVATION, 2024-2032 (IN $ MILLION)

FIGURE 17: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY PATIENT-SPECIFIC CELL THERAPIES, 2024-2032 (IN $ MILLION)

FIGURE 18: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY VACCINE PRODUCTION, 2024-2032 (IN $ MILLION)

FIGURE 19: GLOBAL SINGLE-USE BIOPROCESSING MARKET, GROWTH POTENTIAL, BY METHOD, IN 2023

FIGURE 20: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY FILTRATION, 2024-2032 (IN $ MILLION)

FIGURE 21: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)

FIGURE 22: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY MIXING, 2024-2032 (IN $ MILLION)

FIGURE 23: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY PURIFICATION, 2024-2032 (IN $ MILLION)

FIGURE 24: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY CELL CULTURE, 2024-2032 (IN $ MILLION)

FIGURE 25: GLOBAL SINGLE-USE BIOPROCESSING MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023

FIGURE 26: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY BIOPHARMACEUTICAL MANUFACTURERS, 2024-2032 (IN $ MILLION)

FIGURE 27: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY CONTRACT RESEARCH ORGANIZATION AND MANUFACTURERS, 2024-2032 (IN $ MILLION)

FIGURE 28: GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY LIFE SCIENCE R&D COMPANIES AND ACADEMIC RESEARCH, 2024-2032 (IN $ MILLION)

FIGURE 29: NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET, REGIONAL OUTLOOK, 2023 & 2032 (IN %)

FIGURE 30: UNITED STATES SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 31: CANADA SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 32: EUROPE SINGLE-USE BIOPROCESSING MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 33: UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 34: GERMANY SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 35: FRANCE SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 36: ITALY SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 37: SPAIN SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 38: BELGIUM SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 39: POLAND SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 40: REST OF EUROPE SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 41: ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 42: CHINA SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 43: JAPAN SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 44: INDIA SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 45: SOUTH KOREA SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 46: THAILAND SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 47: VIETNAM SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 48: INDONESIA SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 49: AUSTRALIA & NEW ZEALAND SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 50: REST OF ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 51: REST OF WORLD SINGLE-USE BIOPROCESSING MARKET, REGIONAL OUTLOOK, 2023 & 2032 (IN %)

FIGURE 52: LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FIGURE 53: MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET, 2024-2032 (IN $ MILLION)

FAQ’s

FAQs

Single-use bioprocessing refers to bioprocessing equipment and workflows designed for use by one person. It enables small scale bioprocessing.

Benchtop bioreactors, automated microfluidic devices, small chromatography systems, and single-use mixers and bioreactors are examples of some of the single-use bioprocessing products.

Academic labs, startups, and small biotech companies use single-use bioprocessing equipment for R&D, process development, and small-batch production.